Log in

Catalent News Headlines (NYSE:CTLT)

$58.98
+0.18 (+0.31 %)
(As of 02/23/2020 04:00 PM ET)
Today's Range
$58.21
Now: $58.98
$59.16
50-Day Range
$55.93
MA: $59.68
$62.95
52-Week Range
$39.09
Now: $58.98
$68.78
Volume788,704 shs
Average Volume1.29 million shs
Market Capitalization$8.64 billion
P/E Ratio70.21
Dividend YieldN/A
Beta1.7

Headlines

Catalent (NYSE CTLT) News Headlines

Source:
DateHeadline
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2028 - Yahoo FinanceCatalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2028 - Yahoo Finance
finance.yahoo.com - February 20 at 6:45 PM
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2028 - Business WireCatalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2028 - Business Wire
www.businesswire.com - February 20 at 1:44 PM
Catalent to Host Workshop Demonstrating Advantages of Integrated Biologics Development Solutions in London, U.K. - Yahoo FinanceCatalent to Host Workshop Demonstrating Advantages of Integrated Biologics Development Solutions in London, U.K. - Yahoo Finance
finance.yahoo.com - February 20 at 1:44 PM
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2028Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2028
finance.yahoo.com - February 20 at 1:44 PM
Catalent Pharma Solutions, Inc. -- Moodys assigns B3 rating to Catalents notes offeringCatalent Pharma Solutions, Inc. -- Moody's assigns B3 rating to Catalent's notes offering
finance.yahoo.com - February 19 at 5:09 PM
Catalent launches €450M debt offering - Seeking AlphaCatalent launches €450M debt offering - Seeking Alpha
seekingalpha.com - February 19 at 7:08 AM
Catalent Announces Launch of Private Offering of €450 Million of Senior Unsecured Notes Due 2028 - Yahoo FinanceCatalent Announces Launch of Private Offering of €450 Million of Senior Unsecured Notes Due 2028 - Yahoo Finance
finance.yahoo.com - February 19 at 7:08 AM
Catalent, Inc. to Present at the 9th Annual SVB Leerink Global Healthcare Conference - Yahoo FinanceCatalent, Inc. to Present at the 9th Annual SVB Leerink Global Healthcare Conference - Yahoo Finance
finance.yahoo.com - February 18 at 7:43 PM
Catalent, Inc. to Present at the 9th Annual SVB Leerink Global Healthcare ConferenceCatalent, Inc. to Present at the 9th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 18 at 7:43 PM
Insider Buying: Catalent Inc (NYSE:CTLT) Director Buys 2,000 Shares of StockInsider Buying: Catalent Inc (NYSE:CTLT) Director Buys 2,000 Shares of Stock
www.americanbankingnews.com - February 14 at 7:16 PM
Catalent and Zumutor Biologics Collaborate to Manufacture First-in-Class mAb to Treat Solid Tumors - Yahoo FinanceCatalent and Zumutor Biologics Collaborate to Manufacture First-in-Class mAb to Treat Solid Tumors - Yahoo Finance
finance.yahoo.com - February 11 at 10:39 PM
Catalent Completes Acquisition of MaSTherCell - Business WireCatalent Completes Acquisition of MaSTherCell - Business Wire
www.businesswire.com - February 10 at 7:52 PM
Catalent Completes Acquisition of MaSTherCellCatalent Completes Acquisition of MaSTherCell
finance.yahoo.com - February 10 at 7:52 PM
Zacks: Analysts Anticipate Catalent Inc (NYSE:CTLT) Will Post Quarterly Sales of $712.61 MillionZacks: Analysts Anticipate Catalent Inc (NYSE:CTLT) Will Post Quarterly Sales of $712.61 Million
www.americanbankingnews.com - February 9 at 4:06 AM
Q3 2020 Earnings Estimate for Catalent Inc Issued By Jefferies Financial Group (NYSE:CTLT)Q3 2020 Earnings Estimate for Catalent Inc Issued By Jefferies Financial Group (NYSE:CTLT)
www.americanbankingnews.com - February 7 at 11:07 AM
 Analysts Anticipate Catalent Inc (NYSE:CTLT) Will Announce Earnings of $0.53 Per Share Analysts Anticipate Catalent Inc (NYSE:CTLT) Will Announce Earnings of $0.53 Per Share
www.americanbankingnews.com - February 7 at 6:34 AM
Research Analysts Offer Predictions for Catalent Incs FY2020 Earnings (NYSE:CTLT)Research Analysts Offer Predictions for Catalent Inc's FY2020 Earnings (NYSE:CTLT)
www.americanbankingnews.com - February 6 at 11:53 AM
Q3 2020 EPS Estimates for Catalent Inc (NYSE:CTLT) Lifted by KeyCorpQ3 2020 EPS Estimates for Catalent Inc (NYSE:CTLT) Lifted by KeyCorp
www.americanbankingnews.com - February 6 at 10:07 AM
Research Analysts Set Expectations for Catalent Incs Q3 2020 Earnings (NYSE:CTLT)Research Analysts Set Expectations for Catalent Inc's Q3 2020 Earnings (NYSE:CTLT)
www.americanbankingnews.com - February 6 at 10:06 AM
Catalent Makes $315 Million Acquisition in Cellular Medicine - Motley FoolCatalent Makes $315 Million Acquisition in Cellular Medicine - Motley Fool
www.fool.com - February 5 at 5:36 PM
US$70.88 - Thats What Analysts Think Catalent, Inc. Is Worth After These Results - Yahoo FinanceUS$70.88 - That's What Analysts Think Catalent, Inc. Is Worth After These Results - Yahoo Finance
finance.yahoo.com - February 5 at 12:35 PM
Catalent Inc to Post Q2 2021 Earnings of $0.52 Per Share, First Analysis Forecasts (NYSE:CTLT)Catalent Inc to Post Q2 2021 Earnings of $0.52 Per Share, First Analysis Forecasts (NYSE:CTLT)
www.americanbankingnews.com - February 5 at 10:27 AM
US$70.88 - That's What Analysts Think Catalent, Inc. Is Worth After These ResultsUS$70.88 - That's What Analysts Think Catalent, Inc. Is Worth After These Results
finance.yahoo.com - February 5 at 7:34 AM
Catalent Inc (NYSE:CTLT) Given Average Rating of "Buy" by AnalystsCatalent Inc (NYSE:CTLT) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - February 4 at 2:11 PM
Catalent (CTLT) Prices Common Share Offering for Gross Proceeds of Approx. $500M - StreetInsider.comCatalent (CTLT) Prices Common Share Offering for Gross Proceeds of Approx. $500M - StreetInsider.com
www.streetinsider.com - February 4 at 10:06 AM
Robert W. Baird Boosts Catalent (NYSE:CTLT) Price Target to $67.00Robert W. Baird Boosts Catalent (NYSE:CTLT) Price Target to $67.00
www.americanbankingnews.com - February 4 at 9:58 AM
Catalent (NYSE:CTLT) Price Target Raised to $67.00 at Morgan StanleyCatalent (NYSE:CTLT) Price Target Raised to $67.00 at Morgan Stanley
www.americanbankingnews.com - February 4 at 8:49 AM
Catalent (NYSE:CTLT) Releases  Earnings Results, Beats Expectations By $0.06 EPSCatalent (NYSE:CTLT) Releases Earnings Results, Beats Expectations By $0.06 EPS
www.americanbankingnews.com - February 4 at 8:04 AM
Catalent +2% premarket on raising guidance and revenue beat - Seeking AlphaCatalent +2% premarket on raising guidance and revenue beat - Seeking Alpha
seekingalpha.com - February 3 at 10:44 PM
Catalent, Inc. Announces Pricing of Public Offering of Common Stock - Yahoo FinanceCatalent, Inc. Announces Pricing of Public Offering of Common Stock - Yahoo Finance
finance.yahoo.com - February 3 at 10:44 PM
Edited Transcript of CTLT earnings conference call or presentation 3-Feb-20 1:15pm GMTEdited Transcript of CTLT earnings conference call or presentation 3-Feb-20 1:15pm GMT
finance.yahoo.com - February 3 at 10:44 PM
Catalent, Inc. Announces Pricing of Public Offering of Common StockCatalent, Inc. Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - February 3 at 10:44 PM
Catalent: Fiscal 2Q Earnings Snapshot - Yahoo FinanceCatalent: Fiscal 2Q Earnings Snapshot - Yahoo Finance
finance.yahoo.com - February 3 at 5:44 PM
Catalent launches $500M equity offering - Seeking AlphaCatalent launches $500M equity offering - Seeking Alpha
seekingalpha.com - February 3 at 5:44 PM
Whats in the Offing for New Residentials (NRZ) Q4 Earnings? - NasdaqWhat's in the Offing for New Residential's (NRZ) Q4 Earnings? - Nasdaq
www.nasdaq.com - February 3 at 5:44 PM
Catalent Inc (CTLT) Q2 2020 Earnings Call Transcript - Motley FoolCatalent Inc (CTLT) Q2 2020 Earnings Call Transcript - Motley Fool
www.fool.com - February 3 at 5:44 PM
Catalent To Buy Cell Therapy CDMO MasTherCell For $315MCatalent To Buy Cell Therapy CDMO MasTherCell For $315M
finance.yahoo.com - February 3 at 5:44 PM
Catalent, Inc. Announces Public Offering of Common StockCatalent, Inc. Announces Public Offering of Common Stock
finance.yahoo.com - February 3 at 5:44 PM
Form 8-K Catalent, Inc. For: Feb 02 - StreetInsider.comForm 8-K Catalent, Inc. For: Feb 02 - StreetInsider.com
www.streetinsider.com - February 3 at 12:43 PM
Stock Alert: Catalent Inc. (CTLT) Shares Hit 52-Week High - NasdaqStock Alert: Catalent Inc. (CTLT) Shares Hit 52-Week High - Nasdaq
www.nasdaq.com - February 3 at 12:43 PM
Catalent (CTLT) Matches Q2 Earnings Estimates - Yahoo FinanceCatalent (CTLT) Matches Q2 Earnings Estimates - Yahoo Finance
finance.yahoo.com - February 3 at 12:43 PM
Catalent, Inc. Reports Second Quarter Fiscal 2020 Results - Business WireCatalent, Inc. Reports Second Quarter Fiscal 2020 Results - Business Wire
www.businesswire.com - February 3 at 12:43 PM
Catalent (CTLT) Matches Q2 Earnings EstimatesCatalent (CTLT) Matches Q2 Earnings Estimates
finance.yahoo.com - February 3 at 12:43 PM
Catalent (NYSE:CTLT) Issues FY 2020
Pre-Market Earnings GuidanceCatalent (NYSE:CTLT) Issues FY 2020 Pre-Market Earnings Guidance
www.americanbankingnews.com - February 3 at 9:05 AM
Catalent (CTLT) Tops Q2 EPS by 1c, Revenues Beat; Raises FY20 Revenue Guidance Above Consensus - StreetInsider.comCatalent (CTLT) Tops Q2 EPS by 1c, Revenues Beat; Raises FY20 Revenue Guidance Above Consensus - StreetInsider.com
www.streetinsider.com - February 3 at 7:42 AM
Catalent To Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million, Creating an Industry-Leading Cell & Gene Therapy Platform - Business WireCatalent To Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million, Creating an Industry-Leading Cell & Gene Therapy Platform - Business Wire
www.businesswire.com - February 3 at 7:42 AM
Catalent, Inc. Reports Second Quarter Fiscal 2020 Results - Yahoo FinanceCatalent, Inc. Reports Second Quarter Fiscal 2020 Results - Yahoo Finance
finance.yahoo.com - February 3 at 7:42 AM
Catalent To Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million, Creating an Industry-Leading Cell & Gene Therapy PlatformCatalent To Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million, Creating an Industry-Leading Cell & Gene Therapy Platform
finance.yahoo.com - February 3 at 7:42 AM
Catalent, Inc. Reports Second Quarter Fiscal 2020 ResultsCatalent, Inc. Reports Second Quarter Fiscal 2020 Results
finance.yahoo.com - February 3 at 7:42 AM
Insurers Take Aim at Big Pharma. This Small-Cap Stock Stands to Win. - Motley FoolInsurers Take Aim at Big Pharma. This Small-Cap Stock Stands to Win. - Motley Fool
www.fool.com - January 30 at 12:12 PM
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel